Clinical outcomes of patients with breast cancer in a phase I clinic: The M. D. Anderson Cancer Center experience

被引：0
|
作者：
Wheler, J. J. [1 ]
Tsimberidou, A. [1 ]
Moulder, S. [1 ]
Cristofanill, M. [1 ]
Hong, D. [1 ]
Naing, A. [1 ]
Pathak, R. [1 ]
Liu, S. [1 ]
Feng, L. [1 ]
Kurzrock, R. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1054
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center
    Naoto T. Ueno
    Aman U. Buzdar
    Sonja E. Singletary
    Frederick C. Ames
    Marsha D. McNeese
    Frankie A. Holmes
    Richard L. Theriault
    Eric A. Strom
    Barbara J. Wasaff
    Lina Asmar
    Debbie Frye
    Gabriel N. Hortobagyi
    Cancer Chemotherapy and Pharmacology, 1997, 40 : 321 - 329
  • [42] The role of the electrocardiogram (ECG) in phase I drug development in patients with cancer: The University of Texas M. D. Anderson Cancer Center experience with 8,966 ECGs.
    Rodrigues, H. Veasey
    Naing, A.
    Hong, D. S.
    Falchook, G. S.
    Fu, S.
    Wheler, J. J.
    Tsimberidou, A. M.
    Moulder, S. L.
    Janku, F.
    Wen, S.
    Fessahaye, S. N.
    Golden, E. C.
    Westerhold, D. I.
    Ewer, M.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
    Goldstein, Jennifer B.
    Tang, Chad
    Hess, Kenneth R.
    Hong, David
    Subbiah, Vivek
    Janku, Filip
    Fu, Siqing
    Karp, Daniel D.
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Wheler, Jennifer
    Zinner, Ralph
    Javle, Milind
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Fogelman, David R.
    Meric-Bernstam, Funda
    Piha-Paul, Sarina A.
    ONCOTARGET, 2017, 8 (50) : 87163 - 87173
  • [44] Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: The University of Texas M. D. Anderson Cancer Center experience
    Dong, Wenli
    Berry, Donald A.
    Bevers, Therese B.
    Kau, Shu-Wan
    Hsu, Limin
    Theriault, Richard L.
    Shen, Yu
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (05) : 1096 - 1103
  • [45] Toxicity in 1,181 patients with advanced solid tumors treated in phase I clinical trials of predominantly targeted agents: The M. D. Anderson Cancer Center experience.
    Wheler, J. J.
    Teimberidou, A. M.
    Wen, S.
    Naing, A.
    Hong, D. S.
    Falchook, G. S.
    Piha-Paul, A.
    Fu, S.
    Moulder, S. L.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Five-year outcome of patients with squamous cell carcinoma of the breast: the University of Texas M. D. Anderson Cancer Center experience.
    Hennessy, BT
    Krishnamurthy, S
    Valero, V
    Hortobagyi, G
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S63 - S63
  • [47] Introduction -: New Approaches in the Management of Breast Cancer -: The University of Texas M. D. Anderson Cancer Center Investigators' Workshop
    Ajani, JA
    ONCOLOGY-NEW YORK, 2001, 15 (05): : 5 - 6
  • [48] Surgical management of growing teratoma syndrome: The M. D. Anderson Cancer Center Experience - Editorial comment
    Lotan, Yair
    JOURNAL OF UROLOGY, 2007, 177 (04): : 1334 - 1334
  • [49] Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience
    Rodney, Alan J.
    Tannir, Nizar M.
    Siefker-Radtke, Arlene O.
    Liu, Ping
    Walsh, Garrett L.
    Millikan, Randall E.
    Swisher, Stephen G.
    Tu, Shi-Ming
    Pagliaro, Lance C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (06) : 879 - 885
  • [50] Pentostatin in advanced T-cell lymphoid malignancies: Experience at M. D. Anderson Cancer Center
    Kurzrock, R
    ANNALS OF ONCOLOGY, 2005, 16 : 258 - 258
12345